Cyclo(.alpha.R)-.alpha.-hydroxy-4-(4-morpholinyl)benzenepropanoyl-N-methyl-L-leucyl-(2R)-2-hydroxypr

For research use only. Not for therapeutic Use.

  • CAT Number: M093470
  • CAS Number: 155030-63-0
  • Molecular Formula: C60H90N6O14
  • Molecular Weight: 1119.40
  • Purity: ≥95%
Inquiry Now

Cyclo(αR)-α-hydroxy-4-(4-morpholinyl)benzenepropanoyl-N-methyl-L-leucyl-(2R)-2-hydroxypr(Cat No.:M093470)is a cyclic compound designed for advanced biochemical and pharmacological research. Featuring a morpholine group and hydroxybenzene functionality, it offers structural complexity suitable for investigating receptor binding, enzyme inhibition, or drug delivery systems. Its precise stereochemistry, with αR and 2R configurations, provides high specificity in biological interactions, enabling studies in targeted drug design. This compound is valuable in developing therapeutics for conditions involving receptor-ligand interactions, making it a critical tool in medicinal chemistry and biochemical pathway elucidation.


Catalog Number M093470
CAS Number 155030-63-0
Molecular Formula C60H90N6O14
Purity ≥95%
Target Parasite
Storage -20°C
IUPAC Name (3S,6R,9S,12R,15S,18R,21S,24R)-4,6,10,16,18,22-hexamethyl-3,9,15,21-tetrakis(2-methylpropyl)-12,24-bis[(4-morpholin-4-ylphenyl)methyl]-1,7,13,19-tetraoxa-4,10,16,22-tetrazacyclotetracosane-2,5,8,11,14,17,20,23-octone
InChI InChI=1S/C60H90N6O14/c1-37(2)31-47-57(71)77-41(9)53(67)61(11)50(34-40(7)8)60(74)80-52(36-44-17-21-46(22-18-44)66-25-29-76-30-26-66)56(70)64(14)48(32-38(3)4)58(72)78-42(10)54(68)62(12)49(33-39(5)6)59(73)79-51(55(69)63(47)13)35-43-15-19-45(20-16-43)65-23-27-75-28-24-65/h15-22,37-42,47-52H,23-36H2,1-14H3/t41-,42-,47+,48+,49+,50+,51-,52-/m1/s1
InChIKey ZMQMTKVVAMWKNY-YSXLEBCMSA-N
SMILES C[C@@H]1C(=O)N([C@H](C(=O)O[C@@H](C(=O)N([C@H](C(=O)O[C@@H](C(=O)N([C@H](C(=O)O[C@@H](C(=O)N([C@H](C(=O)O1)CC(C)C)C)CC2=CC=C(C=C2)N3CCOCC3)CC(C)C)C)C)CC(C)C)C)CC4=CC=C(C=C4)N5CCOCC5)CC(C)C)C
Reference

</br> 1: Crisford A, Ebbinghaus-Kintscher U, Schoenhense E, Harder A, Raming K, O/’Kelly I, Ndukwe K, O/’Connor V, Walker RJ, Holden-Dye L. The Cyclooctadepsipeptide Anthelmintic Emodepside Differentially Modulates Nematode, Insect and Human Calcium-Activated Potassium (SLO) Channel Alpha Subunits. PLoS Negl Trop Dis. 2015 Oct 5;9(10):e0004062. doi: 10.1371/journal.pntd.0004062. eCollection 2015 Oct 5. PubMed PMID: 26437177; PubMed Central PMCID: PMC4593646.</br> 2: Kulke D, von Samson-Himmelstjerna G, Miltsch SM, Wolstenholme AJ, Jex AR, Gasser RB, Ballesteros C, Geary TG, Keiser J, Townson S, Harder A, Krücken J. Characterization of the Ca2+-gated and voltage-dependent K+-channel Slo-1 of nematodes and its interaction with emodepside. PLoS Negl Trop Dis. 2014 Dec 18;8(12):e3401. doi: 10.1371/journal.pntd.0003401. eCollection 2014 Dec 18. PubMed PMID: 25521608; PubMed Central PMCID: PMC4270693.</br> 3: Buxton SK, Robertson AP, Martin RJ. Diethylcarbamazine increases activation of voltage-activated potassium (SLO-1) currents in Ascaris suum and potentiates effects of emodepside. PLoS Negl Trop Dis. 2014 Nov 20;8(11):e3276. doi: 10.1371/journal.pntd.0003276. eCollection 2014 Nov 20. PubMed PMID: 25411836; PubMed Central PMCID: PMC4238981.</br> 4: Böhm C, Wolken S, Schnyder M, Basso W, Deplazes P, Di Cesare A, Deuster K, Schaper R. Efficacy of Emodepside/Praziquantel Spot-on (Profender®) against adult Aelurostrongylus abstrusus Nematodes in Experimentally Infected Cats. Parasitol Res. 2015 Aug;114 Suppl 1:S155-64. doi: 10.1007/s00436-015-4521-0. PubMed PMID: 26152416.</br> 5: Böhm C, Petry G, Schaper R, Wolken S, Strube C. Prevention of Lactogenic Toxocara cati Infections in Kittens by Application of an Emodepside/Praziquantel Spot-on (Profender®) to the Pregnant Queen. Parasitol Res. 2015 Aug;114 Suppl 1:S175-84. doi: 10.1007/s00436-015-4523-y. PubMed PMID: 26152418.</br> 6: Elmshäuser S, Straehle LC, Kranz J, Krebber R, Geyer J. Brain penetration of emodepside is increased in P-glycoprotein-deficient mice and leads to neurotoxicosis. J Vet Pharmacol Ther. 2015 Feb;38(1):74-9. doi: 10.1111/jvp.12149. Epub 2014 Aug 1. PubMed PMID: 25131706.</br> 7: Miltsch SM, Krücken J, Demeler J, Janssen IJ, Krüger N, Harder A, von Samson-Himmelstjerna G. Decreased emodepside sensitivity in unc-49 γ-aminobutyric acid (GABA)-receptor-deficient Caenorhabditis elegans. Int J Parasitol. 2012 Jul;42(8):761-70. doi: 10.1016/j.ijpara.2012.05.009. Epub 2012 Jun 19. PubMed PMID: 22727682.</br> 8: Holden-Dye L, Crisford A, Welz C, von Samson-Himmelstjerna G, Walker RJ, O/’Connor V. Worms take to the slo lane: a perspective on the mode of action of emodepside. Invert Neurosci. 2012 Jun;12(1):29-36. doi: 10.1007/s10158-012-0133-x. Epub 2012 Apr 27. Review. PubMed PMID: 22539031; PubMed Central PMCID: PMC3360863.</br> 9: Petry G, Altreuther G, Wolken S, Swart P, Kok DJ. Efficacy of emodepside plus toltrazuril oral suspension for dogs (Procox®, Bayer) against Trichuris vulpis in naturally infected dogs. Parasitol Res. 2013 Aug;112 Suppl 1:133-8. doi: 10.1007/s00436-013-3287-5. PubMed PMID: 23756961.</br> 10: De Tommasi AS, Giannelli A, de Caprariis D, Ramos RA, Di Paola G, Crescenzo G, Dantas-Torres F, Baneth G, Otranto D. Failure of imidocarb dipropionate and toltrazuril/emodepside plus clindamycin in treating Hepatozoon canis infection. Vet Parasitol. 2014 Mar 1;200(3-4):242-5. doi: 10.1016/j.vetpar.2013.12.013. Epub 2013 Dec 22. PubMed PMID: 24439769.</br> 11: Krüdewagen EM, Remer C, Deuster K, Schunack B, Wolken S, Crafford D, Fourie J, Stanneck D. Chemical Compatibility and Safety of Imidacloprid/Flumethrin Collar (Seresto®) Concomitantly Used with Imidacloprid/Moxidectin (Advocate®, Advantage® Multi) and Emodepside/Praziquantel (Profender®) Spot-on Formulations. Parasitol Res. 2015 Aug;114 Suppl 1:S55-80. doi: 10.1007/s00436-015-4514-z. PubMed PMID: 26152409.</br> 12: Crisford A, Murray C, O/’Connor V, Edwards RJ, Kruger N, Welz C, von Samson-Himmelstjerna G, Harder A, Walker RJ, Holden-Dye L. Selective toxicity of the anthelmintic emodepside revealed by heterologous expression of human KCNMA1 in Caenorhabditis elegans. Mol Pharmacol. 2011 Jun;79(6):1031-43. doi: 10.1124/mol.111.071043. Epub 2011 Mar 17. PubMed PMID: 21415309; PubMed Central PMCID: PMC3102553.</br> 13: Martin RJ, Buxton SK, Neveu C, Charvet CL, Robertson AP. Emodepside and SL0-1 potassium channels: a review. Exp Parasitol. 2012 Sep;132(1):40-6. doi: 10.1016/j.exppara.2011.08.012. Epub 2011 Sep 3. Review. PubMed PMID: 21910990; PubMed Central PMCID: PMC3262936.</br> 14: Buxton SK, Neveu C, Charvet CL, Robertson AP, Martin RJ. On the mode of action of emodepside: slow effects on membrane potential and voltage-activated currents in Ascaris suum. Br J Pharmacol. 2011 Sep;164(2b):453-70. doi: 10.1111/j.1476-5381.2011.01428.x. PubMed PMID: 21486286; PubMed Central PMCID: PMC3188918.</br> 15: Altreuther G, Gasda N, Adler K, Hellmann K, Thurieau H, Schimmel A, Hutchens D, Krieger KJ. Field evaluations of the efficacy and safety of Emodepside plus toltrazuril (Procox® oral suspension for dogs) against naturally acquired nematode and Isospora spp. infections in dogs. Parasitol Res. 2011 Aug;109 Suppl 1:S21-8. doi: 10.1007/s00436-011-2399-z. PubMed PMID: 21739372.</br> 16: Di Cesare A, Iorio R, Crisi P, Paoletti B, Di Costanzo R, Dimitri CF, Traversa D. Treatment of Troglostrongylus brevior (Metastrongyloidea, Crenosomatidae) in mixed lungworm infections using spot-on emodepside. J Feline Med Surg. 2015 Feb;17(2):181-5. doi: 10.1177/1098612X14533552. Epub 2014 May 2. PubMed PMID: 24793743.</br> 17: Petry G, Kruedewagen E, Bach T, Gasda N, Krieger KJ. Efficacy of Procox® oral suspension for dogs (0.1% emodepside and 2% toltrazuril) against experimental nematode (Toxocara cati and Ancylostoma tubaeforme) infections in cats. Parasitol Res. 2011 Aug;109 Suppl 1:S37-43. doi: 10.1007/s00436-011-2401-9. PubMed PMID: 21739374.</br> 18: Schimmel A, Schroeder I, Altreuther G, Settje T, Charles S, Wolken S, Kok DJ, Ketzis J, Young D, Hutchens D, Krieger KJ. Efficacy of emodepside plus toltrazuril (Procox(®) oral suspension for dogs) against Toxocara canis, Uncinaria stenocephala and Ancylostoma caninum in dogs. Parasitol Res. 2011 Aug;109 Suppl 1:S1-8. doi: 10.1007/s00436-011-2397-1. PubMed PMID: 21739370.</br> 19: Petry G, Kruedewagen E, Kampkoetter A, Krieger K. Efficacy of emodepside/toltrazuril suspension (Procox® oral suspension for dogs) against mixed experimental Isospora felis/Isospora rivolta infection in cats. Parasitol Res. 2011 Aug;109 Suppl 1:S29-36. doi: 10.1007/s00436-011-2400-x. PubMed PMID: 21739373.</br> 20: Welz C, Krüger N, Schniederjans M, Miltsch SM, Krücken J, Guest M, Holden-Dye L, Harder A, von Samson-Himmelstjerna G. SLO-1-channels of parasitic nematodes reconstitute locomotor behaviour and emodepside sensitivity in Caenorhabditis elegans slo-1 loss of function mutants. PLoS Pathog. 2011 Apr;7(4):e1001330. doi: 10.1371/journal.ppat.1001330. Epub 2011 Apr 7. PubMed PMID: 21490955; PubMed Central PMCID: PMC3072372.</br></br></br>

Request a Quote